As of 2024-12-14, the Relative Valuation of Onxeo SA (ALONX.PA) is (1.52) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 0.22 EUR, the upside of Onxeo SA based on Relative Valuation is -808.5%.
The range of the Relative Valuation is (1.40) - (1.82) EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.3x - 14.3x | 10.0x |
| Forward P/E multiples | 11.1x - 15.9x | 14.0x |
| Fair Price | (1.40) - (1.82) | (1.52) |
| Upside | -753.0% - -945.5% | -808.5% |
| Date | P/E |